MONDAY, SEPTEMBER 26, 2016

ECDC proposes three protocols to test rotavirus vaccine efficacy

The European Centre for Disease Control and Prevention announced Tuesday that it will begin assessing the efficacy of the rotavirus immunization across the European Union to determine if vaccination will be recommended in member states.

The World Health Organization Strategic Advisory Group of Experts recommended rotavirus vaccinations for all children in April 2009. Austria, Belgium, Finland and Luxembourg have implemented this recommendation.

The ECDC, however, said that the new vaccine should be further analyzed before being recommended across the EU. It will begin a three-fold process before coming to a conclusion on whether or not to implement SAGE's immunization recommendations across the EU.

Three simple protocols have been announced thus far by the ECDC. The first protocol will study the effectiveness of the rotavirus vaccination in cohort studies, the second protocol will observe a control study to test the vaccine's effectiveness, and the third protocol will analyze the existing impact of the rotavirus vaccination in EU member states.

The rotavirus virus is the most common global cause of gastroenteritis in children. Every child is expected to have come into contact with this virus at least once by the age of five.